FDA Approves Emergent BioSolutions ' Anthrax Vaccine FDA Approves Emergent BioSolutions ' Anthrax Vaccine

Emergent BioSolutions said on Thursday the US Food and Drug Administration has approved its anthrax vaccine for use in adults aged 18 through 65.Reuters Health Information
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news